LIVINGSTON, N.J., June 24 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it is refining its marketing strategy to gain greater access to and penetration of the international dental markets for the STA Single Tooth Anesthesia System(TM) (STA System), CompuDent(R) and related disposable hand pieces.
The new sales strategy, led by Milestone Chairman and Interim CEO Leonard Osser, will focus on increasing hands-on oversight and support of Milestone's existing international distribution network, while also attracting new distributors throughout Europe, Asia and South America. To assist in this endeavor, Milestone welcomes Shaul Koren, founder and CEO of Istrodent Pty Ltd AB and one of Milestone's strongest marketing allies outside of the U.S., as its new international sales director, who will help manage product sales for the Company in all non-domestic markets worldwide.
"Our 10-year relationship with Shaul has proven to be highly beneficial for Milestone," noted Osser. "In many cases, it has been through his introduction to leading distributors and industry influencers in key international regions that has helped our Company to promote awareness and adoption of Milestone's growing portfolio of C-CLAD (Computer-Controlled Local Anesthesia Delivery) solutions by dental professionals around the world. Now tasked with heading up our new global expansion initiative, Shaul, aided by a dedicated in-house sales support group at Milestone, will work to inspire greater sales growth from each of our existing international distributors; as well as work closely with our team to materially increase the size, scope and impact of Milestone's international distributor network."
"Driven by aging population, increasing demand for preventive and cosmetic dental procedures and technological developments such as our STA and CompuDent systems, industry analysts are projecting that the global market for dental supplies will exceed $21.8 billion by 2015 - up from $13 billion in 2005," continued Osser. "With an estimated 800,000 dentists practicing dentistry worldwide, more can and must be done to reach and educate these professionals on the compelling practice and patient benefits afforded by Milestone's advanced injection technologies; so, we intend to get even more proactive, adopting aggressive marketing strategies to ensure that we optimize this high growth opportunity."
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA Single Tooth Anesthesia System(TM), a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com and www.STAis4U.com.
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group Dodi Handy, President and CEO (Twitter: dodihandy) For Media Inquiries: Kathy Addison, Directors, Elite Media Group (Twitter: kathyaddison) 407-585-1080 or via email at email@example.com
|SOURCE Milestone Scientific Inc.|
Copyright©2009 PR Newswire.
All rights reserved